Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
GlobeNewswire
· Generated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales
· $137.5 million..
· Generated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales
· $137.5 million..
CHICAGO, April 15, 2024 (GLOBE NEWSWIRE) -- Beginning April 15^th, Walgreens, a pharmacy and retail leader who plays..
IDFA’s LAC Seal is the only widely recognized, independent verification of live and active yogurt cultures in the..